Caffeine Completed Phase 3 Trials for Primary apnea of premature newborns Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01020357Caffeine for Apnea of Prematurity-Sleep (CAP-S) Study
NCT01408173Clinical Study of Caffeine for Apnea of Prematurity